Tolerability, Pharmacokinetics, and Efficacy of APD371 in Participants With Crohn's Disease Experiencing Abdominal Pain

NCT03155945 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease
Abdominal Pain

Interventions

DRUG: Olorinab

Sponsor

Arena Pharmaceuticals